Innopharmascreen
Incheon, KR · 1 known investors
InnoPharmaScreen develops medicines based on targeted protein degradation (TPD) molecular glues.
Investors · 1
Frequently asked questions
- What does Innopharmascreen do?
- InnoPharmaScreen develops medicines based on targeted protein degradation (TPD) molecular glues.
- Who are Innopharmascreen's investors?
- Innopharmascreen's investors include Aju IB Invesment Corporation.
- Where is Innopharmascreen headquartered?
- Innopharmascreen is headquartered in Incheon, KR.